NEO 15.77 (-0.32%)
US64049M2098Medical Diagnostics & ResearchDiagnostics & Research

NeoGenomics (NEO) Competitor Comparison

We are evaluating the key criteria listed to compare NeoGenomics (NEO) against its competitors in the Diagnostics & Research industry.

Dividend Rank - NEO ranking 25 / 58

These are the competitors of NeoGenomics in the industry Diagnostics & Research ranked by dividend rank
1. Quest Diagnostics DGX
0.57
2. Meridian Bioscience VIVO
0.43
3. PerkinElmer PKI
0.36
4. Waters WAT
0.29
5. Agilent Technologies A
0.29
6. Laboratory Corp of America Holdings LH
0.29
7. Ortho Clinical Diagnostics Holdings OCDX
0.21
8. Medpace Holdings MEDP
0.21
9. Danaher DHR
0.21
10. IQVIA Holdings IQV
0.21
11. IDEXX Laboratories IDXX
0.21
12. Interpace Biosciences IDXG
0.14
13. Mettler-Toledo MTD
0.14
14. National Research NRC
0.14
15. Thermo Fisher Scientific TMO
0.14
16. Psychemedics PMD
0.14
17. Olink Holding OLK
0.14
18. MDxHealth MDXH
0.07
19. Charles River Laboratories CRL
0.07
20. Fulgent Genetics FLGT
0.07
21. Prenetics Global PRE
0.07
22. Myriad Genetics MYGN
0
23. Natera NTRA
0
24. Neogen NEOG
0
25. NeoGenomics NEO
0
26. Neuronetics STIM
0
27. Organovo Holdings ONVO
0
28. Pacific Biosciences of California PACB
0
29. Personalis PSNL
0
30. Precipio PRPO
0
31. Qiagen QGEN
0
32. RadNet RDNT
0
33. Sera Prognostics SERA
0
34. Sotera Health SHC
0
35. Syneos Health SYNH
0
36. Trinity Biotech TRIB
0
37. Twist Bioscience TWST
0
38. SeqLL SQL
0
39. Anixa Biosciences ANIX
0
40. Aspira Womens Health AWH
0
41. bioAffinity Technologies BIAF
0
42. Biodesix BDSX
0
43. Bioventus BVS
0
44. CareDx CDNA
0
45. Co-Diagnostics CODX
0
46. DarioHealth DRIO
0
47. DexCom DXCM
0
48. Enzo Biochem ENZ
0
49. Exact Sciences EXAS
0
50. Exagen XGN
0
51. Global Cord Blood CO
0
52. Guardant Health GH
0
53. Heska HSKA
0
54. Icon ICLR
0
55. Illumina ILMN
0
56. Inotiv NOTV
0
57. Lantheus Holdings LNTH
0
58. MaxCyte MXCT
0

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.